arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

download Export Data

Autonomix Medical, Inc.

AMIX

$1.65 ▲ +0.03 (+1.85%) at close

5 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Autonomix Medical, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $250.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -289.0% ↘

FCF / Share $-0.08 ↗

Trailing P/E —

Price / Book 67.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

5-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-16.71M

↓ -46.5% —

FCF / Share Free cash flow per share

$-0.08

↑ +63.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗
EPS Growth YoY (%)	64.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-515.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-517.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-46.5% Weak ↑ Weak Improving Year-over-year change in net income	26.0% Excellent Excellent Year-over-year change in net income	-675.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	63.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-927.4% Weak Weak Year-over-year change in free cash flow	-195.6% Weak Weak Year-over-year change in free cash flow	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗
Return on Invested Capital (%)	-289.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-143.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-157.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-309.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-224.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-118.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-127.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-230.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-283.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1990%)	-140.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1039%)	-202.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1448%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗
Net Debt (USD)	$-7.00M	$-9.14M	$-8.61M	$-865.00K	—

📊 What does each share earn? 6 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	$0.00	$0.00	—
Basic EPS, GAAP (USD)	$-0.11	$-0.31	$-0.05	$-0.01	—
Free Cash Flow per Share (USD)	$-0.08	$-0.22	$-0.02	$-0.01	—
Book Value per Share (USD)	$0.02	$0.15	$0.02	$0.00	—
Tangible Book Value per Share (USD)	$0.02	$0.15	$0.02	$0.00	—
Basic Weighted Avg Shares (shares)	151.55M	37.09M	307.15M	252.49M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗
Working Capital (USD)	$5.88M	$7.90M	$8.61M	$644.00K	—
Total Equity (USD)	$5.89M	$8.10M	$7.63M	$644.00K	$1.96M

📋 What is driving earnings? 4 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	—
Depreciation Expense (USD)	$12.00K	$183.00K	$81.00K	$0.00	—
Net Income, GAAP (USD)	$-16.71M	$-11.41M	$-15.43M	$-1.99M	—
Operating Cash Flow (USD)	$-12.28M	$-8.26M	$-6.65M	$-1.85M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 18 quarters

Autonomix Medical, Inc.

Analytical Summary

5-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AMIX with peers